Supplementary Table 5 from Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models

crossref(2024)

引用 0|浏览1
暂无评分
摘要

Supplementary Table 5 lists the quantifications of IHC markers in EWS and OS PDX.

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要